Stock Comparison

AMIX vs UNH

Autonomix Medical Inc vs UnitedHealth Group Inc

The Verdict

AMIX takes this one.

Winner

AMIX

Autonomix Medical Inc

5.3

out of 10

Proceed with Caution

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

$4M

Market Cap

$365.5B

N/A

P/E Ratio

30.3

N/A

Profit Margin

2.7%

-228.8%

Return on Equity

12.4%

N/A

Debt-to-Equity

0.8

Aggressive

Overall Risk

Moderate

5.3

DVR Score

0.3

The Deep Dive

AMIX5.3/10

Autonomix Medical Inc. (AMIX) remains an extremely speculative micro-cap with immense 10x growth potential if its proprietary nerve signal analysis platform achieves clinical and regulatory success. The intrinsic market opportunity in nerve-related conditions and the potential competitive advantage are strong. Recent clinical progress, evidenced by abstract acceptance for Digestive Disease Week 20...

Full AMIX Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.